Mon, March 8, 2021

Nathan Rich Upgraded (AMRX) to Strong Buy and Increased Target to $6.5 on, Mar 8th, 2021

Nathan Rich of Goldman Sachs, Upgraded "Amneal Pharmaceuticals, Inc." (AMRX) to Strong Buy and Increased Target from $4 to $6.5 on, Mar 8th, 2021.

Nathan, nor any peers, have made any analyst calls on AMRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30